Effects of Viscous Fibre Containing Foods on Satiety (Gel Form)

NCT ID: NCT02134938

Last Updated: 2014-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess whether low caloric, low energy density, konjac food products are effective in appetite regulation when administered as caloric replacements. It is hypothesized that replacement of typical, balanced, vegetarian meals with konjac food products will have comparable satiety scores, decreased postprandial glucose response, and will not significantly affect subsequent food intake.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Konjac Glucomannan

650g KJM-G

Group Type EXPERIMENTAL

Konjac Glucomannan

Intervention Type DIETARY_SUPPLEMENT

Konjac Noodles (Wellbond Import Export Inc.), Vegan Konjac Shrimp (Sophie's Kitchen), Konjac Gel Cubes

Half Control/Half Konjac Glucomannan

325g KJM-G

Group Type EXPERIMENTAL

Konjac Glucomannan

Intervention Type DIETARY_SUPPLEMENT

Konjac Noodles (Wellbond Import Export Inc.), Vegan Konjac Shrimp (Sophie's Kitchen), Konjac Gel Cubes

Control

0g KJM-G

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Konjac Glucomannan

Konjac Noodles (Wellbond Import Export Inc.), Vegan Konjac Shrimp (Sophie's Kitchen), Konjac Gel Cubes

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy, non-smoking males and females
* Aged 18-70 years
* BMI between 18 - 29.9 kg/m²
* Non-dieters (1-10 score on Stunkard Eating Inventory)

Exclusion Criteria

* Known reported history of liver or kidney disease, diabetes, hypertension, stroke or myocardial infarctions, thyroid disease, Celiac disease/gastrointestinal disease, or AIDS
* Weight change of +/- 3kg in the last 2 months
* Alcohol intake \>2 drinks/day
* Inability to consume KJM-G meals
* Any condition which might jeopardize the health and safety of the subject or study personnel, or adversely affect the study results
* Non-compliance with experimental procedures or safety guidelines
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unity Health Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vladimir Vuksan, PhD

Role: PRINCIPAL_INVESTIGATOR

Risk Factor Modification Centre - St. Michael's Hospital

Alexandra Jenkins (Co-Investigator), RD, PhD

Role: PRINCIPAL_INVESTIGATOR

Risk Factor Modification Centre - St. Michael's Hospital

William Watson (Qualified Investigator), MD

Role: PRINCIPAL_INVESTIGATOR

Department of Family Medicine - St. Michael's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Risk Factor and Modification Centre

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rodney Au-Yeung, BSc

Role: CONTACT

(416) 864-6060 ext. 5526

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KJM-G

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Satiety Response of Four Dietary Fibers
NCT01233024 COMPLETED EARLY_PHASE1